Followers | 199 |
Posts | 21795 |
Boards Moderated | 2 |
Alias Born | 11/07/2005 |
Thursday, January 02, 2020 11:57:25 AM
Ludlow Research Initiates Coverage on GTXO Based on Revenue Growth, and Low Market Valuation
(NEW YORK)–Dec. 13, 2019--Ludlow Research initiated research opinion on GTX Corp (OTCQB: GTXO), a pioneer in the field of wearable GPS, people and asset tracking Location-Based Services (LBS) and Real-Time Location Systems (RTLS), with a ‘speculative’ short-term target of $0.05 to $0.08 per share, based on solid revenue growth and low market valuation.
Ludlow Research has initiated research coverage on GTXO based on strong revenue growth, positive outlook for 2020, and very low market value for their wearable IoT operations.
Key reasons for upgrade:
- A pioneer in Wearable GPS Tracking for Alzheimer and Dementia Patients
- $1.3 Million nine month trailing revenues
- Customers in over 35 countries
- U.S. Military Contractor
- Government or Insurance reimbursement in 3 Countries and 11 States
- Large IP portfolio
- Low Market Cap Valuation
Very Low Market Valuation
As of Dec. 13, 2019, the Company had roughly 75 million shares issued and outstanding, with a market cap of just around $400,000.
But for the purposes of our report, and to be even more conservative with our outlook projections, we are rounding these shares upward to an even 100 million for easier calculation purposes, and to adjust for any future dilution that may or may not occur.
So, even at 100 million shares outstanding, our projected target of $0.05 to $0.08 a share would still only equate to a $5 to $8 million market cap, which we feel is pretty reasonable for an IoT company with growing revenues, increasing gross margins, and technology that can address both military and healthcare needs.
https://ludlowresearch.com/reports
Have a great low float, or killer chart to share with our group of traders?
Post it up on my new board!
Sweet Crude's - Low Float and Chart Plays (please join)
http://investorshub.advfn.com/boards/board.aspx?board_id=21852
Recent MLRT News
- Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 11:48:41 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/18/2023 07:45:29 PM
- Form 253G1 - • Edgar (US Regulatory) • 08/16/2023 12:23:04 PM
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 08/15/2023 04:15:06 AM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 09:09:41 PM
- Shares on the Rise Following New Production Announcement for Wearable Monitoring Device Firm • AllPennyStocks.com • 08/10/2023 02:50:00 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 08/07/2023 08:50:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM